Curr Stem Cell Res Ther. 2018 Jan 5. doi: 10.2174/1574888X13666180105123915. [Epub ahead of print]

Stem cells transplantation in the treatment of patients with liver failure.

Tao YC¹, Wang ML¹, Chen EQ¹, Tang H¹.

Abstract

BACKGROUND:

Liver failure is life-threatening liver disease encompassing a severe acute deterioration of liver function. Emergency liver transplantation is the only curative treatment for liver failure, but is restricted by the severe shortage of organ donors. Stem cell, including embroyonic stem cells, induced pluripotent stem cells, mesenchymal stem cells, hematopoietic stem cells and hepatic progenitor cells, have capacity to proliferate and differentiate and could be used in a variety of liver diseases including hereditary liver diseases, cirrhosis and liver failure.

OBJECTIVE:

We summarized the basic experimental and clinical advances of stem cell transplantation in liver failure treatment, and also discussed the advantages and disadvantage of different stem cells subtype in this field, aiming to provide a perspective on the stem cell-based therapy for liver failure.

RESULTS:

Stem cells, especially mesenchymal stem cells(mainly low immunogenicity and paracrine characteristics) and induced pluripotent stem cells( generation of desired cell type from somatic cell), are feasible candidates for cell therapy in the treatment of liver diseases, but there are some drawbacks remaining to be resolved, such as low engraftment, cryotpreservation methods and tumorigenesis.

CONCLUSION:

Stem cell transplantation is a promising but challenging strategy and paves a new way for curing liver disease. But more efforts need to be made to overcome problems before this new strategy could be safely and effectively applied to humans.

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.